To evaluate the effectiveness and safety of the XEN-Stent for managing unresponsive to medical therapy secondary glaucoma after silicone oil (SO) removal.
Methods
This retrospective chart reviewed 12 patients who underwent vitrectomy and SO endotamponade. They experienced intraocular pressure (IOP) elevation after SO removal despite taking the maximum tolerated glaucoma medication. Eleven eyes underwent an XEN-implant, while 1 underwent an XEN-implant with phacoemulsification/IOL implantation. The primary outcome was to achieve success criteria: IOP <18 mmHg and >20% IOP reduction without medication (complete success) or with medication (qualified success) and without a secondary IOP-lowering procedure. IOP, best-corrected visual acuity (BCVA), and the number of glaucoma medications (Glaucoma Medication Score-GMS) were recorded at baseline, 1 day, 1 week, 1 (M1), 3 (M3), 6 (M6), and 12 (M12) months postoperatively.
Results
Baseline characteristics included males percentage 66.6%, mean age of 61.8 ± 5.7 years, BCVA 0.69 ± 0.3 logMAR, IOP 30 ± 4.2 mmHg, and GMS 3.1 ± 0.5. There was a significant reduction in IOP by 14 ± 1.9 mmHg and GMS by 0.27 ± 0.6 at M12 compared to baseline (p < 0.01), but no significant change in BCVA (p = 0.21). Complete success dropped to 50% (M3), rising to 75% (M6, M12) after needling. Two patients achieved qualified success at M12. Needling was performed in 6 eyes, with 3 requiring a second procedure. Ex-PRESS was required in 1 eye. One eye experienced hypotony and hyphema, which resolved within a week.
Conclusion
XEN implant may be an initial treatment for persistent post SO removal glaucoma with minimal complications. Needling procedures can help maintain or restore surgical success.
RossiTRipandelliG. Pars plana vitrectomy and the risk of ocular hypertension and glaucoma: where are we?J Clin Med2020; 9: 3994.
2.
MansukhaniSABarkmeierAJBakriSJ, et al.The risk of primary open-angle glaucoma following vitreoretinal surgery—A population-based study. Am J Ophthalmol2018; 193: 143–155.
3.
PillaiGSVarkeyRUnnikrishnanUG,et al.Incidence and risk factors for intraocular pressure rise after transconjunctival vitrectomy. Indian J Ophthalmol2020; 8: 812–817.
4.
GeddeSJ. Management of glaucoma after retinal detachment surgery. Curr Opin Ophthalmol2002; 13: 103–109. Review.
5.
AntounJAzarGJabbourE, et al.Vitreoretinal surgery with silicone oil tamponade in primary uncomplicated rhegmatogenous retinal detachment: clinical outcomes and complications. Retina2016; 6: 1906–1912. doi:https://doi.org/10.1097/IAE.0000000000001008
6.
JabbourEAzarGAntounJ, et al.Incidence and risk factors of ocular hypertension following pars Plana vitrectomy and silicone oil injection. Ophthalmologica2018; 40: 129–134.
7.
NicolaiMLassandroNFranceschiA, et al.Intraocular pressure rise linked to silicone oil in retinal surgery: a review. Vision (Basel)2020; 4: 36.
Falkner-RadlerCISmretschnigEGrafA,et al.Outcome after silicone oil removal and simultaneous 360 degrees endolaser treatment. Acta Ophthalmol2011; 89: e46–e51.
10.
MoisseievEOhanaOGershovitchL,et al.Visual prognosis and complications following silicone oil removal. Eur J Ophthalmol2013; 23: 236–241.
11.
MoisseievJBarakAManaimT,et al.Removal of silicone oil in the management of glaucoma in eyes with emulsified silicone. Retina (Philadelphia, Pa.)1993; 13: 290–295.
12.
BrănişteanuDCMoraruABîlhaA. Anatomical results and complications after silicone oil removal. Rom J Ophthalmol2017; 61: 261–266.
13.
El-SaiedHMAbdelhakimMASE. Different surgical modalities for management of persistent glaucoma after silicone oil removal in vitrectomized eyes: one Year Comparative Study. Retina (Philadelphia, Pa.)2017; 37: 1535–1543.
14.
NguyenQHLloydMAHeuerDK, et al.Incidence and management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments. Ophthalmology1992; 99: 1520–1526.
15.
ChaudharyASalinasLGuidottiJ, et al.XEN gel implant: a new surgical approach in glaucoma. Expert Rev Med Devices2018; 15: 47–59.
16.
LewczukKKonopińskaJJabłońskaJ, et al.XEN Gel stent glaucoma implant for the management of glaucoma in naïve patients versus patients with previous glaucoma surgery. J Clin Med2021; 10: 4417.
17.
LewczukKKonopińskaJJabłońskaJ, et al.XEN glaucoma implant for the management of operated uncontrolled glaucoma: results and complications during a long-term follow-up. J Ophthalmol2021; 2021: 2321922.
18.
GroverDSFlynnWJBashfordKP, et al.Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol2017; 813: 25–36.
19.
MansouriKGuidottiJRaoHL, et al.Prospective evaluation of standalone XEN gel stent gel implant and combined phacoemulsification-XEN gel stent gel implant surgery: 1-year results. J Glaucoma2018; 27: 140–147.
20.
VeraVAhmedIIKStalmansI,et al.Gel stent implantation – recommendations for preoperative assessment, surgical technique, and postoperative management. US Ophthalmic Rev2018; 11: 38–46.
21.
FeaAMDurrGMMaroloP, et al.XEN Gel stent®: a comprehensive review on its use as a treatment option for refractory glaucoma. Clinical Ophthalmology (Auckland, N.Z.)2020; 14: 1805–1832.
22.
PoelmanHJPalsJRostamzadP, et al.Efficacy of the XEN gel stent-implant in glaucoma and a meta-analysis of the literature. J Clin Med2021; 10: 1118.
23.
ScheerlinckLMSchellekensPALiemAT, et al.Incidence, risk factors, and clinical characteristics of unexplained visual loss after intraocular silicone oil for Macula-on retinal detachment. Retina (Philadelphia, Pa.)2016; 36: 342–350.
24.
MoyaRChandraABanerjeePJ, et al.The incidence of unexplained visual loss following removal of silicone oil. Eye (Lond)2015; 29: 1477–1482.
25.
ErricoDScrimieriFLRiccardiR,et al.Trabeculectomy versus ex-press glaucoma filtration device in silicomacrophagocytic open angle glaucoma secondary to silicone oil emulsification. Middle East Afr J Ophthalmol2016; 23: 177–182.
26.
IshidaKIiAPaN. Ahmed glaucoma valve surgical outcomes in eyes with and wi-thout silicone oil endotamponade. J Glaucoma2009; 8: 325–330.
27.
ChanCKTarasewiczDGLinSG. Subconjunctival migration of silicone oil through a Baerveldt pars plana glaucoma implant. Br J Ophthalmol2005; 9: 2401.
28.
Al-AswadLANetlandPABellowsAR, et al.Clinical experience with the double-plate ahmed glaucoma valve. Am J Ophthalmol2006; 141: 390–391.
29.
SouzaCTranDHLomanJ, et al.Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol2007; 144: 893–900.
30.
VeraVHorvathC. XEN Gel stent: the solution designed by AqueSys. In: SamplesJRAhmedIIK (eds) Surgical innovations in glaucoma. New York, NY: Springer New York, 2014, pp.1–307. Available from: http://link.springer.com/10.1007/978-1-4614-8348-9.
31.
ZhaoHYuJZongY, et al.Characteristics of silicone oil emulsification after vitrectomy for rhegmatogenous retinal detachment: an ultrasound biomicroscopy study. Front Med (Lausanne)2022; 8: 794786.
32.
FellmanRLGroverDSSmithOU,et al.Rescue of failed XEN-45 gel implant by Nd:YAG shock wave to anterior chamber tip to dislodge hidden intraluminal occlusion. J Glaucoma2021; 30: e338–e343.
33.
ChanYKCheungNChanWSC,et al.Quantifying silicone oil emulsification in patients: are we only seeing the tip of the iceberg?Graefes Arch Clin Exp Ophthalmol2015; 253: 1671–1675.
34.
GreenWLindJTSheybaniA. Review of the XEN gel stent gel stent and InnFocus MicroShunt. Curr Opin Ophthalmol2018; 29: 162–170.
35.
ChenX-zLiangZ-QYangK-Y, et al.The outcomes of XEN gel stent implantation: a systematic review and meta-analysis. Front. Med2022; 9: 804847.
36.
VeraVSheybaniALindfieldD, et al.Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation. Clin Ophthalmol2019; 13: 685–694.
37.
SherwoodMBGriersonIMillarL,et al.Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon capsule in glaucomatous patients. Ophthalmology1989; 96: 327–335.
38.
BaudouinCLiangHHamardP, et al.The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology2008; 115: 109–115.
39.
De GregorioAPedrottiEStevanG, et al.XEN Gel stent glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol Auckl NZ2018; 12: 773–782.
40.
ArnljotsTSKasinaRBykovVJN,et al.Needling with 5-fluorouracil (5-FU) after XEN gel stent implantation: 6-month outcomes. J Glaucoma2018; 27: 893–899.
41.
Ibáñez-MuñozASoto-BiforcosVSChacón-GonzálezM, et al.One-year follow-up of the XEN gel stent® implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol2018; 29: 309.
42.
SmithMCharlesRAbdel-HayA, et al.1-year Outcomes of the XEN gel Stent45 glaucoma implant. Eye (Lond)2019; 33: 761.
43.
MidhaNGillmannKChaudharyA, et al.Efficacy of needling revision after XEN gel stent implantation: a prospective study. J Glaucoma2020; 29: 11–14.
44.
AllanEJJonesJMDingK,et al.Outcomes of bleb revision with mitomycin C after ex-PRESS shunt surgery. J Glaucoma2016; 25: e318–e323.
45.
PonnusamyVNguyenVAnJA. Comparative outcome analysis of bleb needling of fibrotic blebs in the clinic versus the operating room: a retrospective case series. BMC Ophthalmol2021; 21: 115.
46.
TanSZWalkdenAAuL. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond)2018; 32: 324–332.
47.
ArnouldLTheillacVMoranS, et al.Recurrent exposure of XEN gel stent implant and conjunctival erosion. J Glaucoma2019; 28: e37–e40.
48.
LapiraMCronbachNShaikhA. Extrusion and breakage of XEN gel stent resulting in endophthalmitis. J Glaucoma2018; 27: 934–935.
49.
Santamaria-AlvarezJFLillo-SopenaJSanz-MorenoS,et al.Management of conjunctival perforation and XEN gel stent exposure by stent repositioning through the anterior chamber. J Glaucoma2019; 28: e24–e26.
50.
LeeCKSeoJHLimSH. Management of XEN gel stent exposure with conjunctival erosion via rotational conjunctival flap and amniotic membrane transplantation-A case report. Medicina (Kaunas)2022 Nov 2; 58: 1581.
51.
KarimiALindfieldDTurnbullA, et al.A multi-centre interventional case series of 259 ab-interno XEN gel stent gel implants for glaucoma, with and without combined cataract surgery. Eye (Lond)2019; 33: 469–477.
52.
LenzhoferMKersten-GomezISheybaniA, et al.Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clin Exp Ophthalmol2019; 47: 581–587.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
